 |
|
Human RANTES Ultra-Sensitive Kit
|
| This kit provides assay-specific components for the quantitative determination of both natural and recombinant human regulated upon activation, normal T-cell expressed and secreted (RANTES or CCL5) in serum and plasma. |
|
K151BFC-4
|
Human RANTES Ultra-Sensitive Kit |
25 plates |
|
K151BFC-2
|
Human RANTES Ultra-Sensitive Kit |
5 plates |
|
Safety, tolerability and pharmacokinetics of a human anti-IL-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.
van Hartingsveldt B, Nnane IP, Bouman-Thio E, Loza MJ, Piantone A, Davis HM, Petty KJ.
|
Br J Clin Pharmacol. |
2012 |
|
Blood protein concentrations in the first two postnatal weeks associated with early postnatal blood gas derangements among infants born before the 28th week of gestation. The ELGAN Study.
Leviton, A., Allred, E.N., Kuban, K.C., Dammann, O., Fichorova, R.N., O'Shea, T.M., Paneth, N.; for the ELGAN Study Co-Investigators.
|
Cytokine. |
2011 |
|
Persistence after birth of systemic inflammation associated with umbilical cord inflammation.
Leviton, A., Hecht, J.L., Allred, E.N., Yamamoto, H., Fichorova, R.N., Dammann, O.; for the ELGAN Study Investigators.
|
J Reprod Immunol. |
2011 |
|
Systemic responses of preterm newborns with presumed or documented bacteremia.
Leviton, A., O'Shea, M.T., Bednarek, F.J., Allred, E.N., Fichorova, R.N., Dammann, O.; for the ELGAN Study Investigators.
|
Acta Paediatr. |
2011 |
|
Maternal Microbe-Specific Modulation of Inflammatory Response in Extremely Low-Gestational-Age Newborns
Fichorova, R.N., Onderdonk, A.B., Yamamoto, H., Delaney, M.L., DuBois, A.M., Allred, E., Levition, A; for the ELGAN Study Investigators.
|
mBio |
2011 |
|
|
|
|
 |
| Price |
Please call for price |
| Size |
1 plate |
| Catalog No. |
K151BFC-1 |
| Availability |
Usually ships in 1-3 days |
|
Home
Products
K151BFC-1
